pentobarbital will decrease the extent or outcome of venetoclax by affecting hepatic/intestinal enzyme CYP3A4 metabolism.pentobarbital will minimize the level or effect of buprenorphine subdermal implant by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep an eye on Carefully. Check individuals now on buprenorphine subder